Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee - 13/12/17
, Richard D. Granstein, MD b, Sewon Kang, MD c, Mark Mannis, MD d, Martin Steinhoff, MD, PhD e, f, Jerry Tan, MD g, Diane Thiboutot, MD hAbstract |
In 2002, the National Rosacea Society assembled an expert committee to develop the first standard classification of rosacea. This original classification was intended to be updated as scientific knowledge and clinical experience increased. Over the last 15 years, significant new insights into rosacea's pathogenesis and pathophysiology have emerged, and the disorder is now widely addressed in clinical practice. Growing knowledge of rosacea's pathophysiology has established that a consistent multivariate disease process underlies the various clinical manifestations of this disorder, and the clinical significance of each of these elements is increasing as more is understood. This review proposes an updated standard classification of rosacea that is based on phenotypes linked to our increased understanding of disease pathophysiology. This updated classification is intended to provide clearer parameters to conduct investigations, guide diagnosis, and improve treatment.
Le texte complet de cet article est disponible en PDF.Key words : comorbidity, erythema, ocular, papules, pathophysiology, phenotypes, phymas, pustules, rosacea, telangiectasia
Abbreviations used : NRS, RosaQoL
Plan
| Supported by the National Rosacea Society. |
|
| Disclosure: Dr Granstein is a Galderma consultant and Elysium investigator and advisory board member; Dr Kang is a Galderma advisory board member. Dr Tan is a Galderma advisory board member, consultant, speaker, and investigator; a Bayer advisory board member; and a Cipher Roche advisory board member. Drs Gallo, Mannis, Steinhoff, and Thiboutot have no conflicts of interest to declare. |
|
| Reprint requests: National Rosacea Society, 196 James St, Barrington, IL 60010. E-mail: info@rosacea.org. |
Vol 78 - N° 1
P. 148-155 - janvier 2018 Retour au numéro
Article précédent
- A new evidence-based risk stratification system for cutaneous squamous cell carcinoma into low, intermediate, and high risk groups with implications for management
- Christian L. Baum, Adam C. Wright, Juan-Carlos Martinez, Christopher J. Arpey, Jerry D. Brewer, Randall K. Roenigk, Clark C. Otley
- Evidence-based update on rosacea comorbidities and their common physiologic pathways
- Anna D. Holmes, Julia Spoendlin, Anna L. Chien, Hilary Baldwin, Anne Lynn S. Chang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?